New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Prostate cancer treatment can wait for most men, study finds

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by
Oncology January 23,2024
Prostate cancer treatment can wait for most men, study finds

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by
Oncology January 23,2024
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA
Oncology January 23,2024
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA
Oncology January 23,2024
Study shows combining AI models improves breast cancer risk assessment

Study shows combining AI models improves breast cancer risk assessment

byRadiological Society of North AmericaFull-field digital mammograms (right mediolateral oblique view) in a 59-year-old woman show (A) the screening mammogram obtained during the study period an
Oncology January 23,2024
Study shows combining AI models improves breast cancer risk assessment

Study shows combining AI models improves breast cancer risk assessment

byRadiological Society of North AmericaFull-field digital mammograms (right mediolateral oblique view) in a 59-year-old woman show (A) the screening mammogram obtained during the study period an
Oncology January 23,2024
How communication in the tumor microenvironment influences tumor development

How communication in the tumor microenvironment influences tumor development

by Goethe UniversityTissue section of a lung tumor showing different cells in the tumor microenvironment: macrophages (red), collagen-producing macrophages or fibrocytes (yellow), fibroblasts (green).
Oncology January 23,2024
How communication in the tumor microenvironment influences tumor development

How communication in the tumor microenvironment influences tumor development

by Goethe UniversityTissue section of a lung tumor showing different cells in the tumor microenvironment: macrophages (red), collagen-producing macrophages or fibrocytes (yellow), fibroblasts (green).
Oncology January 23,2024
RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

by Melissa Pappas, University of Pennsylvania School of Engineering and Applied ScienceCredit: Unsplash/CC0 Public DomainMultiple myeloma is an incurable bone marrow cancer that kills over 100,000 peo
Oncology January 23,2024
RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

by Melissa Pappas, University of Pennsylvania School of Engineering and Applied ScienceCredit: Unsplash/CC0 Public DomainMultiple myeloma is an incurable bone marrow cancer that kills over 100,000 peo
Oncology January 23,2024
Study indicates who faces highest risk of HPV infection and anal cancer

Study indicates who faces highest risk of HPV infection and anal cancer

by Andrew Smith,Rutgers UniversityElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainPrevious sexually transmitted infectio
Oncology January 23,2024
Study indicates who faces highest risk of HPV infection and anal cancer

Study indicates who faces highest risk of HPV infection and anal cancer

by Andrew Smith,Rutgers UniversityElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainPrevious sexually transmitted infectio
Oncology January 23,2024
Genetically modified herpes virus delivers one-two punch against advanced cancers

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c
Oncology January 23,2024
Genetically modified herpes virus delivers one-two punch against advanced cancers

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c
Oncology January 23,2024
Research finds global surge in cancers among the under 50s over past three decades

Research finds global surge in cancers among the under 50s over past three decades

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThere's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990–2
Oncology January 23,2024
Research finds global surge in cancers among the under 50s over past three decades

Research finds global surge in cancers among the under 50s over past three decades

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThere's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990–2
Oncology January 23,2024
Study: New imaging technique in animal study gives insight to popular supplement's potential role in cancer progression

Study: New imaging technique in animal study gives insight to popular supplement's potential role in cancer progression

by Eric Stann,University of MissouriCredit: Unsplash/CC0 Public DomainWhile previous studies have linked commercial dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to
Oncology January 23,2024
Study: New imaging technique in animal study gives insight to popular supplement's potential role in cancer progression

Study: New imaging technique in animal study gives insight to popular supplement's potential role in cancer progression

by Eric Stann,University of MissouriCredit: Unsplash/CC0 Public DomainWhile previous studies have linked commercial dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to
Oncology January 23,2024
Seeking microscopic clues to beating deadly brain tumors

Seeking microscopic clues to beating deadly brain tumors

by Hackensack Meridian HealthH&E stained sections of patient glioblastoma samples. Higher magnifcation of representative regions are shown in the colored boxes. Histologic features include low (bl
Oncology January 23,2024
Seeking microscopic clues to beating deadly brain tumors

Seeking microscopic clues to beating deadly brain tumors

by Hackensack Meridian HealthH&E stained sections of patient glioblastoma samples. Higher magnifcation of representative regions are shown in the colored boxes. Histologic features include low (bl
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com